• Neurotrophic Keratitis Market to Expand Significantly by 2034, openPR.com Thu, 17 Apr 2025 07:00:00 GMT
• Aviceda Therapeutics Appoints Industry Veteran Dr. Jeffrey Nau as Chief Executive Officer to Lead Next Phase of Growth and Innovat... Business Wire Tue, 01 Apr 2025 07:00:00 GMT
• projected growth and competitive landscape in the glaucoma drainage implant market openPR Mon, 25 Nov 2024 08:42:00 GMT
• dry eye syndrome treatment (evaporative, aqueous deficient) GlobeNewswire Wed, 20 Nov 2024 11:20:08 GMT
• dry eye syndrome treatment (evaporative, aqueous deficient) GlobeNewswire Tue, 19 Nov 2024 16:25:12 GMT
• tyrvaya® (varenicline solution) nasal spray for the treatment of the signs and symptoms of dry eye disease. Drug Topics Thu, 24 Oct 2024 07:00:00 GMT
• perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials Frontiers Mon, 30 Sep 2024 12:18:17 GMT
• opthea limited announces key executive leadership changes and senior hires Ophthalmology Times Sun, 22 Sep 2024 07:00:00 GMT
• nicotinic agonists industry size is booming worldwide with share, size, top key players Moose Gazette Sat, 27 Jul 2024 18:03:44 GMT
• we're not very worried about oyster point pharma's (nasdaq:oyst) cash burn rate Yahoo News Australia Sat, 29 Jun 2024 03:51:15 GMT
• nicotinic agonists market 2030 | karuna pharmaceuticals, sumitomo dainippon pharma co, bms, oyster point ... PrimePair Thu, 20 Jun 2024 10:52:34 GMT
• do institutions own oyster point pharma, inc. (nasdaq:oyst) shares? Yahoo News UK Sun, 09 Jun 2024 09:04:54 GMT
• Tectonic Therapeutic Appoints Daniel Lochner as Chief Financial Officer Business Wire Mon, 03 Jun 2024 07:00:00 GMT
• ers international congress 2016 - us fda, oyster point pharma The Pharma Letter Thu, 16 May 2024 08:03:09 GMT
• analysts have just cut their oyster point pharma, inc. (nasdaq:oyst) revenue estimates by 10% Yahoo Lifestyle Australia Thu, 09 May 2024 17:22:43 GMT
• analysts have just cut their oyster point pharma, inc. (nasdaq:oyst) revenue estimates by 10% Yahoo Lifestyle Australia Wed, 08 May 2024 02:47:00 GMT
• aacr annual meeting 2018 - oyster point pharma, varenicline The Pharma Letter Mon, 06 May 2024 08:24:37 GMT
• how oyster point (oyst) stock stands out in a strong industry Yahoo New Zealand News Thu, 02 May 2024 17:00:40 GMT
• fda approves first nasal spray for chronic dry eyes McKnight's Long-Term Care News Sun, 21 Apr 2024 14:10:38 GMT
• are insiders buying oyster point pharma, inc. (nasdaq:oyst) stock? Yahoo Canada Shine On Fri, 19 Apr 2024 14:11:13 GMT
• are insiders buying oyster point pharma, inc. (nasdaq:oyst) stock? Yahoo Canada Shine On Wed, 17 Apr 2024 21:51:00 GMT
• deloitte report unveils $5–7 billion ai life sciences opportunity TechTarget Thu, 04 Apr 2024 07:00:00 GMT
• moving beyond the drop: ceo provides updates on oyster point's pipeline Ophthalmology Times Wed, 21 Feb 2024 19:07:30 GMT
• gene therapies in ophthalmology clinical trial pipeline GlobeNewswire Mon, 19 Feb 2024 08:00:00 GMT
• kilroy's mega project at oyster point is facing a 6 month delay. here's why The Business Journals Thu, 08 Feb 2024 08:00:00 GMT
• moving beyond the drop: ceo provides updates on oyster point's pipeline Ophthalmology Times Sun, 04 Feb 2024 00:56:15 GMT
• moving beyond the drop: ceo provides updates on oyster point's pipeline Ophthalmology Times Fri, 19 Jan 2024 08:00:00 GMT
• bayer backs chinese biotech with novel heart disease pipeline The Pharma Letter Thu, 11 Jan 2024 08:00:00 GMT
• neurotrophic keratopathy market to grow rapidly at a cagr of 15.4% by 2032, predicts delveinsight PR Newswire Mon, 11 Dec 2023 08:00:00 GMT
• transmucosal drug delivery pipeline report 2023 - stages of ... Business Wire Fri, 24 Nov 2023 15:22:00 GMT
• when managing cases of dry eye, expect the unexpected Ophthalmology Times Fri, 24 Nov 2023 11:03:45 GMT
• mindfulness-based cognitive therapy shows promise in alleviating ... Ophthalmology Times Fri, 24 Nov 2023 11:01:53 GMT
• załącznik do naszego komunikatu prasowego #eulife22 – krótkie ... European Commission Thu, 23 Nov 2023 08:00:00 GMT
• Aptar Pharma pump delivers first nasal spray treatment for dry eye Aptar Sat, 18 Nov 2023 07:59:37 GMT
• annex to our #eulife22 press release - project short summaries European Commission Tue, 14 Nov 2023 08:00:00 GMT
• achieving net-zero in the dry eye disease care pathway | eye Nature.com Mon, 13 Nov 2023 08:00:00 GMT
• viatris reports strong financial and operational results for the ... Viatris Tue, 07 Nov 2023 08:00:00 GMT
• a review of the first anti-evaporative prescription treatment for dry ... AJMC.com Managed Markets Network Fri, 03 Nov 2023 07:00:00 GMT
• pearls for integrating dry eye disease management into your practice Ophthalmology Times Fri, 20 Oct 2023 07:00:00 GMT
• rite aid plans to close over 150 stores after bankruptcy filing: is yours on the list? The Hill Tue, 17 Oct 2023 07:00:00 GMT
• advocacy, pbm reform remain crucial for independent pharmacy survival Drug Topics Thu, 12 Oct 2023 07:00:00 GMT
• okyo pharma files ind with us fda for the development of ok-101 ... Ophthalmology Times Mon, 09 Oct 2023 07:00:00 GMT
• in selling 3 businesses, viatris bids adieu to 10 manufacturing plants, 6,000 employees FiercePharma Mon, 02 Oct 2023 07:00:00 GMT
• FDA Approves Viatris, Ocuphire’s Eye Drops to Reverse Pupil Dilation BioSpace Thu, 28 Sep 2023 07:00:00 GMT
• As Viatris seeks growth in eye care, its Ocuphire-partnered dilation drop Ryzumvi wins FDA nod Fierce Pharma Wed, 27 Sep 2023 07:00:00 GMT
• an aye for the eyes: ocuphire and viatris get an approval BioWorld Online Wed, 27 Sep 2023 07:00:00 GMT
• aav vectors in gene therapy clinical trial pipeline insights |70+ ... Medgadget Fri, 22 Sep 2023 07:00:00 GMT
• annual anti-inflammatory review: the most interesting market ... Healio Fri, 22 Sep 2023 07:00:00 GMT
• dry eye treatment with cryopreserved amniotic membrane | opth Dove Medical Press Tue, 12 Sep 2023 07:00:00 GMT
• landscape architect's goal of nature-based infrastructure PBS NewsHour Tue, 29 Aug 2023 07:00:00 GMT
• sjögren syndrome: a three-part ded treatment plan and insights ... Optometry Times Wed, 23 Aug 2023 07:00:00 GMT
• presbyopia drops are latest reminder that category's future remains ... Healio Thu, 10 Aug 2023 07:00:00 GMT
• Viatris plans to reveal 'significant' divesture this quarter as it moves ahead with strategic revamp Fierce Pharma Wed, 09 Aug 2023 07:00:00 GMT
• viatris says its divestures, return to growth strategy on track FiercePharma Wed, 09 Aug 2023 07:00:00 GMT
• okyo pharma announces plans to initiate trial of ok-101 in ... Ophthalmology Times Tue, 01 Aug 2023 07:00:00 GMT
• blog: how to prepare patients for contact lens wear after cross-linking Healio Tue, 01 Aug 2023 07:00:00 GMT
• he's shucking oysters at dive bars, and we tested the quickest way ... The Philadelphia Inquirer Thu, 20 Jul 2023 07:00:00 GMT
• pearl & mary is carrying on philly's oyster bar tradition. the menu is ... The Philadelphia Inquirer Mon, 17 Jul 2023 07:00:00 GMT
• researchers set sights on commonly bought probiotic for dry eye disease potential Fierce Biotech Tue, 20 Jun 2023 07:00:00 GMT
• researchers set sights on probiotic for dry eye disease FierceBiotech Tue, 20 Jun 2023 07:00:00 GMT
• awaiting fda's decision, aldeyra's dry eye disease drug scores phase 3 win for conjunctivitis Fierce Biotech Thu, 15 Jun 2023 07:00:00 GMT
• aldeyra's dry eye disease drug scores phase 3 conjunctivitis win FierceBiotech Thu, 15 Jun 2023 07:00:00 GMT
• the increasingly critical role of optometrists in neovascular retinal ... Healio Wed, 14 Jun 2023 17:40:19 GMT
• paola-1 and prima study designs. *patients with other epithelial... ResearchGate Tue, 13 Jun 2023 05:32:34 GMT
• personalize treatment options, prioritize patient needs when treating ... Healio Wed, 07 Jun 2023 07:00:00 GMT
• viatris scouts for new board chair as longtime leader robert coury transitions to advisory role FiercePharma Wed, 24 May 2023 07:00:00 GMT
• 2023 sales forecast reaffirmed by viatris on strong demand for newer drugs BW Healthcare World Wed, 10 May 2023 07:00:00 GMT
• bw healthcare world || 2023 sales forecast reaffirmed by viatris on strong demand for newer drugs BW Healthcareworld Wed, 10 May 2023 07:00:00 GMT
• viatris reaffirms 2023 sales forecast on strong demand for newer drugs ETHealthWorld Tue, 09 May 2023 07:00:00 GMT
• viatris reaffirms 2023 sales forecast on strong demand for newer drugs Reuters.com Mon, 08 May 2023 07:00:00 GMT
• aav vectors in gene therapy pipeline experiences momentum: GlobeNewswire Thu, 27 Apr 2023 07:00:00 GMT
• 6 of the top biotech companies to know about in south san francisco Labiotech.eu Thu, 20 Apr 2023 07:00:00 GMT
• here's how you can collect $100 in dividends every month The Motley Fool Wed, 05 Apr 2023 07:00:00 GMT
• delveinsight highlights major advances, transformative therapies ... Medgadget Thu, 23 Mar 2023 07:00:00 GMT
• how mississippi spent millions that failed to save its oyster reefs ... ProPublica Wed, 22 Mar 2023 07:00:00 GMT
• chutes & ladders—biogen names stelios papadopoulos' successor Fierce Biotech Fri, 10 Mar 2023 08:00:00 GMT
• novabay pharmaceuticals inc. announces the launch of avenova ... Ophthalmology Times Wed, 08 Mar 2023 08:00:00 GMT
• neurostimulation, neuromodulation offer exciting new approaches for dry eye Healio Tue, 07 Mar 2023 08:00:00 GMT
• eyebio announces first asset in innovative pipeline of retinal disease treatments and appoints industry leaders to executive team Business Wire Mon, 06 Mar 2023 08:00:00 GMT
• Promising growth next year, Viatris names Celgene vet Scott Smith its next CEO Fierce Pharma Mon, 27 Feb 2023 08:00:00 GMT
• biocon raises rs 1067 crore from kotak to fund biosimilars deal Medical Dialogues Thu, 23 Feb 2023 08:00:00 GMT
• becoming a one-stop shop for respiratory illness testing Drug Topics Tue, 21 Feb 2023 08:00:00 GMT
• nutritional supplements can improve acceptance, durability of in ... Ophthalmology Times Fri, 17 Feb 2023 08:00:00 GMT
• Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences TechTarget Thu, 26 Jan 2023 08:00:00 GMT
• aerovate therapeutics appoints donald santel to its board of directors citybiz Mon, 23 Jan 2023 08:00:00 GMT
• JPM23: Viatris lays out plans to become ophthalmology leader and pull down $1B in eye care sales Fierce Pharma Thu, 12 Jan 2023 08:00:00 GMT
• jpm23, day 3: fda's califf weighs in on accelerated approvals, abbvie ceo touts humira defense FiercePharma Wed, 11 Jan 2023 08:00:00 GMT
• viatris closes acquisitions of oyster point pharma and famy life sciences, establishes new eyecare division Vision Monday Fri, 06 Jan 2023 08:00:00 GMT
• cooley continues climb in us and global m&a and private equity ... Cooley LLC Fri, 06 Jan 2023 08:00:00 GMT
• viatris closes acquisitions of famy life sciences, oyster point pharma to establish eye care division Medical Dialogues Wed, 04 Jan 2023 08:00:00 GMT
• Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division PR Newswire Tue, 03 Jan 2023 08:00:00 GMT
• viatris closes acquisitions of famy life sciences, oyster point pharma to establish eye care division Medical Dialogues Tue, 03 Jan 2023 08:00:00 GMT
• 2022 turns out to be another unspectacular year for pharma and ... The Pharma Letter Mon, 02 Jan 2023 08:00:00 GMT
• dry eye disease pipeline insight report: 50+ companies | delveinsight openPR Fri, 30 Dec 2022 08:00:00 GMT
• sahara study looks at dry eye treatments covered by insurers Optometry Times Thu, 29 Dec 2022 08:00:00 GMT
• viatris inc. to participate in 41st annual j.p. morgan healthcare ... PR Newswire Fri, 23 Dec 2022 08:00:00 GMT
• viatris to commercialize calliditas’ nefecon in japan The Pharma Letter Tue, 13 Dec 2022 08:00:00 GMT
• biocon biologics completes $3 billion acquisition of viatris’ biosimilars Managed Healthcare Executive Mon, 12 Dec 2022 08:00:00 GMT
• oyster point investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and... Barchart Wed, 07 Dec 2022 08:00:00 GMT
• does your vaccine storage system protect patients and your business? Drug Topics Tue, 29 Nov 2022 08:00:00 GMT
• viatris and oyster point – mylan all over again? (nasdaq:oyst) Seeking Alpha Thu, 17 Nov 2022 08:00:00 GMT
• investor alert: the m&a class action firm announces the investigation of oyster point pharma, inc. - oyst PR Newswire Mon, 14 Nov 2022 08:00:00 GMT
• aacr annual meeting 2018 - famy life sciences, oyster point pharma The Pharma Letter Sun, 13 Nov 2022 08:00:00 GMT
• Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights GlobeNewswire Thu, 10 Nov 2022 08:00:00 GMT
• White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc. White & Case LLP Thu, 10 Nov 2022 08:00:00 GMT
• here’s why viatris (nasdaq:vtrs) shares soared 13% recently TipRanks Tue, 08 Nov 2022 16:56:58 GMT
• Viatris agrees to acquire Oyster Point and Famy Life Sciences Pharmaceutical Technology Tue, 08 Nov 2022 08:00:00 GMT
• Centerview grows role as go-to adviser for biopharma dealmaking BioPharma Dive Tue, 08 Nov 2022 08:00:00 GMT
• Viatris to create ophthalmology franchise via two M&A deals The Pharma Letter Tue, 08 Nov 2022 08:00:00 GMT
• ocuphire enters global license agreement with famy for nyxol development Healio Tue, 08 Nov 2022 08:00:00 GMT
• viatris’ far-sighted binocular move brings aboard oyster, famy pipelines BioWorld MedTech Tue, 08 Nov 2022 08:00:00 GMT
• nov. 7 quick takes: viatris buying oyster point a year after dry eye approval BioCentury Tue, 08 Nov 2022 08:00:00 GMT
• 2 eye drug developers to be acquired in deals worth $700m+ InvisionMag Tue, 08 Nov 2022 08:00:00 GMT
• healthcare firm offers us$295m for ophthalmology co. trending company Streetwise Reports Tue, 08 Nov 2022 08:00:00 GMT
• makeover sees viatris move further away from generics Evaluate Pharma Tue, 08 Nov 2022 08:00:00 GMT
• cravath, swaine & moore biotech & pharmaceuticals health car... Law.com Tue, 08 Nov 2022 08:00:00 GMT
• oyster point pharma skyrockets on viatris deal - tipranks.com TipRanks Mon, 07 Nov 2022 14:35:34 GMT
• Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris GlobeNewswire Mon, 07 Nov 2022 08:00:00 GMT
• Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M Fierce Pharma Mon, 07 Nov 2022 08:00:00 GMT
• Viatris Acquires Oyster Point, Gains Access to Ophthalmic Pipeline BioSpace Mon, 07 Nov 2022 08:00:00 GMT
Oyster Point Pharma, Inc(NASDAQ:OYST)

Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. The company's lead product candidate is OC-01, a nicotinic acetylcholine receptor ago...
Website: http://www.oysterpointrx.com
Founded: 2015
IPO Price: $16 (Oct 31, 2019)
Full Time Employees: 62 (May 2021)
CEO: Jeffrey A. Nau
Sector: Healthcare
Industry: Biotechnology
